|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-3-14
|
|
pubmed:abstractText |
Preterm infants receiving dexamethasone for respiratory morbidity frequently suffer restricted growth. The aim of this study was to investigate the interactions between dexamethasone treatment regimen and circulating IGFBP-3 and IGF-I levels, and the associations between these variables and linear growth rate in preterm babies receiving dexamethasone for chronic lung disease of prematurity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
235-42
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11207639-Analysis of Variance,
pubmed-meshheading:11207639-Dexamethasone,
pubmed-meshheading:11207639-Drug Administration Schedule,
pubmed-meshheading:11207639-Female,
pubmed-meshheading:11207639-Glucocorticoids,
pubmed-meshheading:11207639-Humans,
pubmed-meshheading:11207639-Infant, Newborn,
pubmed-meshheading:11207639-Infant, Premature,
pubmed-meshheading:11207639-Infant, Premature, Diseases,
pubmed-meshheading:11207639-Insulin-Like Growth Factor Binding Protein 3,
pubmed-meshheading:11207639-Insulin-Like Growth Factor I,
pubmed-meshheading:11207639-Leg,
pubmed-meshheading:11207639-Lung Diseases, Obstructive,
pubmed-meshheading:11207639-Male,
pubmed-meshheading:11207639-Regression Analysis,
pubmed-meshheading:11207639-Time Factors
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Growth restriction in dexamethasone-treated preterm infants may be mediated by reduced IGF-I and IGFBP-3 plasma concentrations.
|
|
pubmed:affiliation |
Research Centre for Developmental Medicine and Biology, University of Auckland, New Zealand.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
